This policy brief provides an overview of the WHO Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy.

The objectives of these guidelines are to provide recommendations outlining a public health approach to managing people presenting with advanced HIV disease, and to provide guidance on the timing of initiation of antiretroviral therapy (ART) for all people living with HIV.

This policy brief provides advice on a phased approach to transitioning to new WHO-recommended HIV treatment regimens. The target audience includes country HIV programme managers, procurement agencies, implementing partners, and other relevant parties.

This technical brief summarizes essential information and existing WHO recommendations for HIV prevention, diagnosis, treatment and care among transgender populations.

New WHO interim guidelines contain recommendations regarding preferred first-line regimens for adults, adolescents and children initiating ART, which now include DTG and RAL.

New Consolidated guidelines on HIV testing services from WHO recommend standardized HIV testing strategies to correctly diagnose HIV infection.

The sexual partners and drug injecting partners of people diagnosed with HIV infection have an increased probability of also being HIV-positive. Assisted HIV partner notification services are a simple and effective way to reach these partners, many of whom are undiagnosed and unaware of their HIV exposure, and may welcome support and an opportunity to test for HIV.

HIV self-testing (HIVST) is an empowering and innovative way to reach more people with HIV and help achieve the first of the United Nation’s 90–90–90 targets – for 90% of all people with HIV to know their status by 2020.

New Consolidated guidelines on HIV testing services from the WHO recommend that lay providers who are trained can, using rapid diagnostic tests, independently conduct safe and effective HIV testing services.